(Q37049217)

17 August 2017

1 reference

title

Regulatory T cells: what role do they play in antitumor immunity in patients with head and neck cancer? (English)

1 reference

17 August 2017

0 references

Osama Alhamarneh

1

1 reference

17 August 2017

Shoba M P Amarnath

series ordinal

2

1 reference

17 August 2017

Nicholas D Stafford

series ordinal

3

1 reference

17 August 2017

John Greenman

series ordinal

4

1 reference

17 August 2017

publication date

1 February 2008

1 reference

17 August 2017

1 reference

17 August 2017

volume

30

1 reference

17 August 2017

issue

2

1 reference

17 August 2017

page(s)

251-261

1 reference

Impairment of T-cell activation in head and neck cancer in situ and in vitro: strategies for an immune restoration

17 August 2017

cites work

1 reference

Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells

21 January 2018

1 reference

TGF-beta-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling

21 January 2018

1 reference

Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism

21 January 2018

1 reference

Bone marrow is a preferred site for homeostatic proliferation of memory CD8 T cells

21 January 2018

1 reference

Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells.

21 January 2018

1 reference

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

21 January 2018

1 reference

CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.

21 January 2018

1 reference

Proliferation requirements of cytomegalovirus-specific, effector-type human CD8+ T cells

21 January 2018

1 reference

CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine

21 January 2018

1 reference

CTLA-4 blockade enhances the therapeutic effect of an attenuated poxvirus vaccine targeting p53 in an established murine tumor model

21 January 2018

1 reference

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

21 January 2018

1 reference

7 January 2021

Regulatory/suppressor T cells in health and disease

1 reference

7 January 2021

Maturation of circulating dendritic cells and imbalance of T-cell subsets in patients with squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention

1 reference

7 January 2021

Update on immunology of head and neck cancer.

1 reference

7 January 2021

Cancer immunotherapy: moving beyond current vaccines

1 reference

7 January 2021

Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer

1 reference

7 January 2021

Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck

1 reference

7 January 2021

The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells

1 reference

7 January 2021

Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer

1 reference

7 January 2021

TGF beta signaling in health and disease

1 reference

7 January 2021

Mechanisms of tumor evasion from the immune response.

1 reference

7 January 2021

Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses

1 reference

7 January 2021

HLA class I antigen loss, tumor immune escape and immune selection

1 reference

7 January 2021

Immunobiology of head and neck cancer

1 reference

7 January 2021

Regulatory T cells, tumour immunity and immunotherapy

1 reference

7 January 2021

Protective mechanisms of head and neck squamous cell carcinomas from immune assault

1 reference

7 January 2021

Regulatory T cells: key controllers of immunologic self-tolerance

1 reference

7 January 2021

Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T cells

1 reference

7 January 2021

Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes

1 reference

7 January 2021

Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.

1 reference

7 January 2021

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

1 reference

7 January 2021

Regulatory T cells and tumor immunity

1 reference

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

7 January 2021

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

7 January 2021

Foxp3 and natural regulatory T cells: key to a cell lineage?

1 reference

7 January 2021

GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations

1 reference

7 January 2021

Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function

1 reference

7 January 2021

Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells

1 reference

7 January 2021

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

1 reference

7 January 2021

Neuropilin-1: a surface marker of regulatory T cells

1 reference

7 January 2021

Role of LAG-3 in regulatory T cells.

1 reference

7 January 2021

MHC class II expression identifies functionally distinct human regulatory T cells

1 reference

7 January 2021

Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin

1 reference

7 January 2021

Natural regulatory T cells and self-tolerance

1 reference

7 January 2021

Interleukin 2 signaling is required for CD4(+) regulatory T cell function

1 reference

7 January 2021

Regulatory T cells in autoimmmunity*.

1 reference

7 January 2021

Mechanisms of suppression by suppressor T cells

1 reference

7 January 2021

Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4 CD25 T cells with PD-1-dependent regulatory activities

1 reference

7 January 2021

Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoire

1 reference

7 January 2021

In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro

1 reference

7 January 2021

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo

1 reference

7 January 2021

Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity

1 reference

7 January 2021

Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice

1 reference

7 January 2021

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

1 reference

7 January 2021

Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected].

1 reference

7 January 2021

A Comparative Study between T Regulatory Type 1 and CD4+CD25+ T Cells in the Control of Inflammation

1 reference

7 January 2021

Regulatory T-cell compartmentalization and trafficking

1 reference

7 January 2021

Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells.

1 reference

7 January 2021

Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals.

1 reference

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

7 January 2021

Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses

1 reference

7 January 2021

Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer

1 reference

7 January 2021

CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression

1 reference

7 January 2021

Regulatory T cells in ovarian cancer: biology and therapeutic potential

1 reference

7 January 2021

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

7 January 2021

Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population

1 reference

7 January 2021

Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites

1 reference

7 January 2021

Increase in circulating Foxp3+CD4+CD25(high) regulatory T cells in nasopharyngeal carcinoma patients

1 reference

7 January 2021

Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck

1 reference

7 January 2021

CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers

1 reference

7 January 2021

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

1 reference

7 January 2021

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

1 reference

7 January 2021

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells

1 reference

7 January 2021

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

1 reference

7 January 2021

Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells

1 reference

7 January 2021

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

1 reference

7 January 2021

The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors

1 reference

7 January 2021

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

1 reference

7 January 2021

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

7 January 2021

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

1 reference

7 January 2021

Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells

1 reference

7 January 2021

Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro

1 reference

7 January 2021

CD25+ CD4+ regulatory T-cells in cancer

1 reference

7 January 2021

Immunoregulatory T cells in tumor immunity

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.20739

1 reference

17 August 2017

1 reference